![Journal cover image](https://secure.syndetics.com/index.aspx?isbn=/lc.gif&issn=2152-2669&client=dukeuniv)
Poster: CT-314 Multicenter Long-Term Follow Up of Allogeneic Hematopoietic Stem Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials
Publication
, Conference
Lin, C; Schwarzbach, A; Montesinos, P; Stiff, P; Cutler, C; Parikh, S; Brunstein, C; Lindemans, C; Hanna, R; Koh, LP; Maziarz, R; Keating, A ...
Published in: Clinical Lymphoma, Myeloma and Leukemia
September 28, 2022
Duke Scholars
Published In
Clinical Lymphoma, Myeloma and Leukemia
ISSN
2152-2669
Publication Date
September 28, 2022
Volume
22
Issue
Supp 2
Start / End Page
S442 / S442
Location
Houston, TX
Publisher
Elsevier
Conference Name
Society of Hematologic Oncology Annual Meeting
Related Subject Headings
- Prospective Studies
- Multicenter Studies as Topic
- Humans
- Hematopoietic Stem Cell Transplantation
- Follow-Up Studies
- Disease-Free Survival
- 3211 Oncology and carcinogenesis
- 3201 Cardiovascular medicine and haematology
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Lin, C., Schwarzbach, A., Montesinos, P., Stiff, P., Cutler, C., Parikh, S., … Horwitz, M. (2022). Poster: CT-314 Multicenter Long-Term Follow Up of Allogeneic Hematopoietic Stem Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials. In Clinical Lymphoma, Myeloma and Leukemia (Vol. 22, pp. S442–S442). Houston, TX: Elsevier.
Lin, Chenyu, Aurelie Schwarzbach, Pau Montesinos, Patrick Stiff, Corey Cutler, Suhag Parikh, Claudio Brunstein, et al. “Poster: CT-314 Multicenter Long-Term Follow Up of Allogeneic Hematopoietic Stem Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials.” In Clinical Lymphoma, Myeloma and Leukemia, 22:S442–S442. Elsevier, 2022.
Lin C, Schwarzbach A, Montesinos P, Stiff P, Cutler C, Parikh S, et al. Poster: CT-314 Multicenter Long-Term Follow Up of Allogeneic Hematopoietic Stem Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials. In: Clinical Lymphoma, Myeloma and Leukemia. Elsevier; 2022. p. S442–S442.
Lin, Chenyu, et al. “Poster: CT-314 Multicenter Long-Term Follow Up of Allogeneic Hematopoietic Stem Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials.” Clinical Lymphoma, Myeloma and Leukemia, vol. 22, no. Supp 2, Elsevier, 2022, pp. S442–S442.
Lin C, Schwarzbach A, Montesinos P, Stiff P, Cutler C, Parikh S, Brunstein C, Lindemans C, Hanna R, Koh LP, Maziarz R, Keating A, Hwang W, Rezvani A, Valcarcel D, Fernandes J, Badell I, Jagasia M, Frankfurt O, Ram R, McGuirk J, Kurtzberg J, Sanz G, Simantov R, Horwitz M. Poster: CT-314 Multicenter Long-Term Follow Up of Allogeneic Hematopoietic Stem Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical Trials. Clinical Lymphoma, Myeloma and Leukemia. Elsevier; 2022. p. S442–S442.
![Journal cover image](https://secure.syndetics.com/index.aspx?isbn=/lc.gif&issn=2152-2669&client=dukeuniv)
Published In
Clinical Lymphoma, Myeloma and Leukemia
ISSN
2152-2669
Publication Date
September 28, 2022
Volume
22
Issue
Supp 2
Start / End Page
S442 / S442
Location
Houston, TX
Publisher
Elsevier
Conference Name
Society of Hematologic Oncology Annual Meeting
Related Subject Headings
- Prospective Studies
- Multicenter Studies as Topic
- Humans
- Hematopoietic Stem Cell Transplantation
- Follow-Up Studies
- Disease-Free Survival
- 3211 Oncology and carcinogenesis
- 3201 Cardiovascular medicine and haematology
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences